Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition)Haowen Tang, Chaoliu Dai, Ze Zhang et al.|BioScience Trends|2024Cited by 20
Dual-Target Inhibitors─Discovery of Novel Diphenyl-(Thio)ether-Containing Benzoxaborole Derivatives as Potential Antifungal and Herbicidal AgentsPei Zhang, Yu‐Cheng Gu, Chun‐Bao Duan et al.|Journal of Agricultural and Food Chemistry|2025Cited by 7
Clinical practice status of the adjuvant therapy in hepatocellular carcinoma (HCC): A survey of Chinese hepatobiliary surgeons.Hui‐Chuan Sun, Haiqing Wang, Jia Fan et al.|Journal of Clinical Oncology|2022Cited by 1